The outcome of these challenges on the IRA, and the effects of the IRA on our business and the healthcare industry in general are not yet known.
All entries for: TScan Therapeutics
November 12, 2025
TScan Therapeutics
Neutral Outlook
Waltham, MA
51-200 employees
On May 12, 2025, the Trump Administration published Executive Order 14297, “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients,” which generally, among other things, directs the federal government to establish and communicate most-favored-nation price targets to pharmaceutical manufacturers to bring prices for American patients in line with comparably developed nations.